• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中肿瘤坏死因子-α信号的临床方面。

Clinical aspects of tumor necrosis factor-α signaling in hepatocellular carcinoma.

机构信息

Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.

出版信息

Curr Pharm Des. 2014;20(17):2799-808. doi: 10.2174/13816128113199990587.

DOI:10.2174/13816128113199990587
PMID:23944370
Abstract

Tumor necrosis factor alpha (TNF-α) is a multi-functional cytokine that regulates a variety of signaling pathways implicated in inflammation, immunity, cell death (apoptosis), cell survival (anti-apoptosis), and even tumorigenesis. TNF-α is predominantly produced by macrophages (or Kupffer cells within the liver), but generated by lymphoid cells, astrocytes, endothelial cells, and smooth muscle cells to some degree. In the liver, TNF-α not only serves as a key mediator of hepatocyte apoptosis resulting in the liver damage, but also plays an important role in cellular proliferation leading to liver regeneration or even hepatocarcinogenesis. TNF-α may indirectly contribute to carcinogenesis via various inflammatory conditions such as alcoholic and non-alcoholic fatty liver diseases and chronic viral hepatitis. On the one hand, in inflammation, TNF-α induces apoptosis repeatedly and subsequently enhances the chance of formation of anomalous cells during the process of regeneration and dysplasia. On the other hand, TNF-α exerts as an anti-angiogenic factor depending on its concentration. It shows an anti-tumorous effect by increasing vascular permeability in the tumors. When it is perfused in combination with chemotherapeutic drugs using isolated hepatic infusion, TNF-α may increase the responsiveness of hepatocellular carcinoma (HCC) or metastatic cancers to anti-cancer agents as isolated limb perfusion methods in an unresectable soft tissue sarcoma or melanoma. This article reviews the TNF-α signaling pathway in hepatocarcinogenesis and the new challenge of TNF-α as a new therapeutic strategy in HCC.

摘要

肿瘤坏死因子-α(TNF-α)是一种多功能细胞因子,可调节多种信号通路,这些信号通路与炎症、免疫、细胞死亡(凋亡)、细胞存活(抗凋亡)甚至肿瘤发生有关。TNF-α主要由巨噬细胞(或肝脏中的库普弗细胞)产生,但也由淋巴样细胞、星形胶质细胞、内皮细胞和平滑肌细胞在一定程度上产生。在肝脏中,TNF-α不仅作为导致肝损伤的肝细胞凋亡的关键介质,而且在细胞增殖中发挥重要作用,导致肝再生甚至肝癌发生。TNF-α可能通过各种炎症情况间接促进癌症发生,如酒精性和非酒精性脂肪性肝病和慢性病毒性肝炎。一方面,在炎症中,TNF-α反复诱导细胞凋亡,随后增加了在再生和发育不良过程中形成异常细胞的机会。另一方面,TNF-α作为一种抗血管生成因子取决于其浓度。它通过增加肿瘤中的血管通透性来发挥抗肿瘤作用。当使用隔离肝输注与化疗药物联合灌注时,TNF-α可能会增加肝细胞癌(HCC)或转移性癌症对癌症药物的反应性,就像在不可切除的软组织肉瘤或黑色素瘤中使用隔离肢体灌注方法一样。本文综述了 TNF-α在肝癌发生中的信号通路以及 TNF-α作为 HCC 新治疗策略的新挑战。

相似文献

1
Clinical aspects of tumor necrosis factor-α signaling in hepatocellular carcinoma.肝细胞癌中肿瘤坏死因子-α信号的临床方面。
Curr Pharm Des. 2014;20(17):2799-808. doi: 10.2174/13816128113199990587.
2
Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.表皮生长因子受体信号在肝细胞癌中的作用:炎症激活和新的细胞内调控机制。
Dig Dis. 2012;30(5):524-31. doi: 10.1159/000341705. Epub 2012 Oct 24.
3
Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells.肿瘤坏死因子-α通过激活肝祖细胞促进肝细胞癌发生。
Cancer Lett. 2018 Oct 10;434:22-32. doi: 10.1016/j.canlet.2018.07.001. Epub 2018 Jul 4.
4
TNF-dependent signaling pathways in liver cancer: promising targets for therapeutic strategies?肝癌中 TNF 依赖的信号通路:治疗策略的有前途靶点?
Dig Dis. 2012;30(5):500-7. doi: 10.1159/000341700. Epub 2012 Oct 24.
5
Prognostic and Therapeutic Values of Tumor Necrosis Factor-Alpha in Hepatocellular Carcinoma.肿瘤坏死因子-α在肝细胞癌中的预后及治疗价值
Med Sci Monit. 2016 Oct 14;22:3694-3704. doi: 10.12659/msm.899773.
6
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.细胞死亡与肝癌发生:细胞凋亡信号通路的失调。
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:213-9. doi: 10.1111/j.1440-1746.2010.06582.x.
7
Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma.肿瘤坏死因子相关凋亡诱导配体(TRAIL)/TRAIL受体途径对干扰素-α/5-氟尿嘧啶抗肝细胞癌抗肿瘤作用的部分贡献。
Clin Cancer Res. 2004 Dec 1;10(23):7884-95. doi: 10.1158/1078-0432.CCR-04-0794.
8
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
9
Distinct role of interleukin-6 and tumor necrosis factor receptor-1 in oval cell- mediated liver regeneration and inflammation-associated hepatocarcinogenesis.白细胞介素-6和肿瘤坏死因子受体-1在卵圆细胞介导的肝再生及炎症相关肝癌发生中的不同作用
Oncotarget. 2016 Oct 11;7(41):66635-66646. doi: 10.18632/oncotarget.11365.
10
The synergistic effect of sorafenib and TNF-α inhibitor on hepatocellular carcinoma.索拉非尼与肿瘤坏死因子-α抑制剂对肝细胞癌的协同作用。
EBioMedicine. 2019 Feb;40:11-12. doi: 10.1016/j.ebiom.2019.01.007. Epub 2019 Jan 14.

引用本文的文献

1
High-Risk PNPLA3 rs738409 Genotype Is Associated with Higher Concentrations of CCL2 in Liver Transplant Candidates with Alcoholic End-Stage Liver Disease.高危PNPLA3 rs738409基因型与酒精性终末期肝病肝移植受者较高的CCL2浓度相关。
Medicina (Kaunas). 2025 Jul 18;61(7):1293. doi: 10.3390/medicina61071293.
2
Wogonoside alleviates the proliferation and promotes the apoptosis in liver cancer cells by regulating PI3K/Akt signaling pathway.汉黄芩苷通过调节PI3K/Akt信号通路减轻肝癌细胞的增殖并促进其凋亡。
Discov Oncol. 2025 Feb 26;16(1):244. doi: 10.1007/s12672-025-01995-5.
3
Assessing TGF-β Prognostic Model Predictions for Chemotherapy Response and Oncogenic Role of FKBP1A in Liver Cancer.
评估 TGF-β 预后模型预测化疗反应和 FKBP1A 在肝癌中的致癌作用。
Curr Pharm Des. 2024;30(39):3131-3152. doi: 10.2174/0113816128326151240820105525.
4
Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma.外周血单个核细胞中预测性三标志物panel 用于检测肝细胞癌。
Sci Rep. 2024 Mar 29;14(1):7527. doi: 10.1038/s41598-024-58158-9.
5
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements.肝癌中γδ T细胞的免疫调节网络与治疗:最新趋势与进展
J Clin Transl Hepatol. 2024 Mar 28;12(3):287-297. doi: 10.14218/JCTH.2023.00355. Epub 2024 Jan 8.
6
Polyhydroxylated Fullerene C(OH) Nanofilms Promote the Mesenchymal-Epithelial Transition of Human Liver Cancer Cells via the TGF-β1/Smad Pathway.多羟基化富勒烯C(OH)纳米膜通过TGF-β1/Smad信号通路促进人肝癌细胞的间充质-上皮转化
J Inflamm Res. 2023 Aug 29;16:3739-3761. doi: 10.2147/JIR.S415378. eCollection 2023.
7
TNFR2 is a potent prognostic biomarker for post-transplant lung metastasis in patients with hepatocellular carcinoma.肿瘤坏死因子受体2(TNFR2)是肝细胞癌患者移植后肺转移的一种有效的预后生物标志物。
Chin J Cancer Res. 2023 Feb 28;35(1):66-80. doi: 10.21147/j.issn.1000-9604.2023.01.07.
8
Specific S100 Proteins Bind Tumor Necrosis Factor and Inhibit Its Activity.特定的 S100 蛋白结合肿瘤坏死因子并抑制其活性。
Int J Mol Sci. 2022 Dec 15;23(24):15956. doi: 10.3390/ijms232415956.
9
Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma.环状RNA hsa_circ_0062682与YBX1结合并促进肝细胞癌的肿瘤发生。
Cancers (Basel). 2022 Sep 19;14(18):4524. doi: 10.3390/cancers14184524.
10
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer.抑瘤素M:从细胞内信号传导到肝癌治疗靶点
Cancers (Basel). 2022 Aug 30;14(17):4211. doi: 10.3390/cancers14174211.